What Does The Hamilton Depression Rating Scale Measure In Methamphetamine Users? | 62178
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2464

Journal of Addiction Research & Therapy received 2464 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

What does the hamilton depression rating scale measure in methamphetamine users?

5th International Conference and Exhibition on Addiction Research & Therapy

Tracy L Hellem

Montana State University College of Nursing, USA

Posters & Accepted Abstracts: J Addict Res Ther

DOI: 10.4172/2155-6105.C1.028

The Hamilton Depression Rating Scale (HAMD) is widely used in studies to measure change in the severity of depression. There are reports of established reliability and validity of the HAMD in both inpatient and outpatient psychiatric patients. However, there are no published psychometric studies of the HAMD in a methamphetamine using population. Given that the symptoms of depression and intoxication or withdrawal from methamphetamine overlap, it is possible that the HAMD does not measure severity of depression in individuals who use methamphetamine. Thus, we are conducting a psychometric evaluation of the HAMD in methamphetamine users with and without depression. This evaluation is currently underway, and we anticipate having results in 6-8 weeks.

Tracy L Hellem completed the PhD program at the University of Utah’s College of Nursing in 2015. She has worked with methamphetamine users with comorbid depression for 5 years. She has authored 14 manuscripts of systematic reviews, clinical trials and magnetic resonance spectroscopy studies. Dr. Hellem is an Assistant Professor at Montana State University’s College of Nursing where she conducts a clinical trial of comorbid depression and anxiety among individuals who use methamphetamine.

Email: [email protected]